A new clinical study is focused on researching the possibility of treating COVID-19 patients with two common and widely available drugs: naltrexone and ketamine. The research is being conducted by the Beaumont Hospital in Royal Oak, Michigan.
The goal of this research is to see if these two drugs can lessen the severity of COVID-19 symptoms by combating the virus during the beginning stages, before the symptoms begin to manifest. The hope is that this will prevent patients with mild cases from worsening to the point where they need ventilators.
This study is a randomized study for patients 18-years and older who have been tested positive for COVID-19. Naltrexone has generally been a drug used for treating alcoholism and opiate addiction, while ketamine has been used to treat depression and anxiety. The anti-inflammatory properties of these medications may be able to treat the inflammation that causes COVID-19 symptoms.
The ultimate goal of these two drugs is to reduce the autoimmune and inflammatory stages of COVID-19, which destroy normal tissue cells.
In the clinical study, naltrexone or placebo will be given to patients with early symptoms of COVID-19 infection, whereas ketamine will be given later, if the participants progress further with the virus. If a patient is in a more advanced stage of COVID-19, they will be given the option to receive ketamine for COVID-19. Patients will continue to receive traditional COVID-19 treatments during the study, with blood work performed constantly by physicians. All patients will be contacted one month after being released to evaluate the outcome of the study.
The study, as of April 2020, has 500 participants, and iOS slated to last through May 2021. The study has been approved by the Food and Drug Administration (FDA).
Of course, we are not offering ketamine for COVID-19, but we appreciate how this medication has been rediscovered over the past 20 years, presenting the medical world with a myriad of miracles, from the treatment of severe cases of depression to preventing PTSD to promoting sobriety amongst alcoholics and drug addicts.
During COVID-19, we are open and operating. If you are feeling more depressed or anxious than usual, please contact us for a free consultation to see if you are a candidate for ketamine infusions at our Modesto, CA ketamine clinic.